Search results for "Cirrhosis"
MKSAP quiz: Complications of hepatitis C-related cirrhosis
This month's quiz asks readers to evaluate a 58-year-old man at a follow-up visit for hepatitis C-related cirrhosis complicated by nonbleeding small esophageal varices and ascites.
https://gastroenterology.acponline.org/archives/2017/07/28/4.htm
28 Jul 2017
New HCV drug combo approved
The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.
https://gastroenterology.acponline.org/archives/2017/07/28/10.htm
28 Jul 2017
NAFLD practice guidance issued for screening, treatment
The guidance, from the American Association for the Study of Liver Diseases, notes that routine screening for nonalcoholic fatty liver disease (NAFLD) in a primary care setting or obesity clinics is not typically recommended due to uncertainties in long-term benefits and cost-effectiveness.
https://gastroenterology.acponline.org/archives/2017/07/28/2.htm
28 Jul 2017
Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response
A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.
https://gastroenterology.acponline.org/archives/2017/07/28/11.htm
28 Jul 2017
Nearly all patients in study achieved sustained virologic response after 12 weeks of new HCV treatment
The drug combination appeared effective in adults with HCV genotypes 1, 2, 4, 5, or 6 infection and compensated cirrhosis in the industry-funded trial.
https://gastroenterology.acponline.org/archives/2017/08/25/3.htm
25 Aug 2017
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing insurance restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://gastroenterology.acponline.org/archives/2017/08/25/6.htm
25 Aug 2017
Sepsis-3 better than SIRS in patients with cirrhosis and infection
Compared to systemic inflammatory response syndrome (SIRS) criteria, both Sepsis-3 criteria and the quick Sequential Organ Failure Assessment (qSOFA) tool had significantly better discrimination for in-hospital mortality.
https://gastroenterology.acponline.org/archives/2017/09/22/2.htm
22 Sep 2017
ACP, CDC issue best practice advice on HBV
Clinicians should screen for hepatitis B virus (HBV) in patients at high risk, such as those born in countries where the HBV prevalence is 2% or higher, men who have sex with men, patients who require immunosuppressive therapy, or patients with end-stage renal disease.
https://gastroenterology.acponline.org/archives/2017/11/28/7.htm
28 Nov 2017
Earlier colorectal cancer screening recommended for patients with cystic fibrosis
The Cystic Fibrosis Colorectal Cancer Screening Task Force based its recommendations on a review of the literature and a modeling study of screening strategies for colorectal cancer that estimated the costs and benefits of screening in patients with cystic fibrosis.
https://gastroenterology.acponline.org/archives/2018/01/26/3.htm
26 Jan 2018
HCV treatment was successful among patients who used injection drugs
The open-label, single-arm, industry-funded phase 4 trial included patients who had used injection drugs within six months and had chronic hepatitis C virus (HCV), recruited at 19 sites in seven countries.
https://gastroenterology.acponline.org/archives/2018/01/26/2.htm
26 Jan 2018